ACIU
AC Immune Ltd
2.70$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -112.8% | – | – | – | -207.8% | – | – | – | – | -200.5% | |
| – | +1.7% | -3.7% | -3.1% | +108.6% | +65.7% | +76.3% | +16.1% | +22.3% | -2.0% | -6.1% | -2.4% | +10.6% | |
| – | -18.0% | +157.1% | +143.9% | +19.9% | +59.5% | +12.5% | +44.2% | +0.9% | -19.3% | +31.1% | +25.3% | -19.6% | |
| – | +93.7% | -483.6% | – | – | -32.5% | -40.6% | +105.8% | -138.7% | – | – | – | – | |
| – | – | – | -86.6% | -160.3% | – | +211.8% | -180.9% | – | -223.3% | – | – | -106.0% | |
| – | -48.6% | +90.6% | +268.4% | +100.4% | +3.1% | +1.5% | -9.5% | +54.5% | -53.0% | -35.4% | -28.1% | +49.2% | |
| – | -47.4% | +86.3% | +268.4% | +104.9% | +1,639.2% | +108.8% | – | -289.4% | – | +176.2% | -260.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +194.1% | +180.2% | -99.9% | +156,990.1% | -99.9% | -244.9% | -100.0% | – | – | – | – | |
| – | – | -1.4% | +0.8% | +0.0% | -170.5% | – | -101.9% | – | -102.5% | -3.7% | +24.6% | +50.2% | |
| – | -2.1% | +183.4% | +183.6% | -99.7% | +40,260.9% | -54.6% | -101.6% | – | -103.3% | – | -102.6% | -13.0% | |
| – | – | – | +3.4% | -136.8% | – | +15.7% | -188.1% | – | – | – | -190.0% | – | |
| – | – | – | -114.9% | – | – | – | -214.8% | – | – | – | – | -202.7% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.